Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Digitoxin intoxication during concomitant use of amiodarone

    S. Läer, H. Scholz, I. Buschmann, M. Thoenes in European Journal of Clinical Pharmacology (1998)

  2. No Access

    Article

    The acute effects of intravenously administered mibefradil, a new calcium antagonist, on the electrophysiologic characteristics of the human heart

    Objective : This multicenter, double-blind, placebo-controlled, parallel-group study was designed to assess the acute effects of intravenous mibefradil on the electrophysiologic characte...

    M. Rosenquist, B. Brembilla-Perrot in European Journal of Clinical Pharmacology (1997)

  3. No Access

    Article

    Cilazapril in Congestive Heart Failure

    The haemodynamic effects of a single dose of cilazapril 2.5 or 5mg were studied in 33 patients with stable chronic congestive heart failure who were receiving digitalis and diuretics. Subsequently, a double-bl...

    Dr W. Kiowski, H. Drexler, T. Meinertz, M. Zuber, R. Ritz, F. Burkart, H. Just in Drugs (1991)

  4. No Access

    Chapter and Conference Paper

    Indikationsbereiche von Klasse-I-Antiarrhythmika — differentialtherapeutische Aspekte bei ventrikulären Herzrhythmusstörungen

    Während Anfang der achtziger Jahre die prognostische Bedeutung ventrikulärer Arrhythmieformen als weitgehend gesichert angesehen und eine entsprechende antiarrhythmischen Therapie verhältnismäßig freizügig geh...

    Dr. M. Zehender, S. Hohnloser, T. Meinertz in Medikamentöse Behandlung des Postinfarktpa… (1991)

  5. No Access

    Chapter and Conference Paper

    Calcium Antagonists in Silent Myocardial Ischemia — Preliminary Results with Nisoldipine

    The use of calcium channel blockers was shown to be effective in the treatment of symptomatic and, more recently, of asymptomatic myocardial ischemia. In this continuing study we evaluated the efficacy of niso...

    T. Meinertz, M. Zehender, H. Just in Nisoldipine 1987 (1987)

  6. No Access

    Article

    Factors responsible for interindividual differences in the dose requirement of phenprocoumon

    The total and unbound plasma concentrations of phenprocoumon and the prothrombin complex activity were determined in 51 patients on phenprocoumon.

    D. Trenk, H. Althen, E. Jähnchen, T. Meinertz in European Journal of Clinical Pharmacology (1987)

  7. No Access

    Chapter

    Grundlagen der Wirkung sympathikomimetischer Stoffe

    Im nachfolgenden Kapitel werden zunächst einige für die klinische Praxis relevante Wirkungen sympathikomimetischer Stoffe an Organsystemen beschrieben und entsprechend ihren Angriffsorten eingeteilt und charak...

    T. Meinertz, H. Scholz in Therapie mit Sympathikomimetika (1987)

  8. No Access

    Chapter and Conference Paper

    Akutwirkungen der neuen inotropen Substanz OPC-8212

    In den letzten Jahren sind zahlreiche inotrop wirkende Pharmaka zur Therapie der Herzinsuffizienz entwickelt worden [5]. Aus klinischer Sicht sind besonders diejenigen Substanzen von Interesse, welche für die ...

    G. Hasenfuss, H. Sievert, W. Busch in Vasoaktive Substanzen bei Herzinsuffizienz (1986)

  9. No Access

    Article

    Experience in the Long Term Use of New Antiarrhythmic Drugs

    T. Meinertz, M. K. Zehender, A. Geibel, N. Treese, T. Hofmann, W. Kasper, T. Pop in Drugs (1985)

  10. No Access

    Chapter

    Echocardiographic Studies in Cardiomyopathies

    Cardiomyopathies comprise a large and inhomogenous group of myocardial diseases. The term primary cardiomyopathy has been proposed for those cases in which a causal factor could not be found.

    W. Kasper, T. Hoffmann, H. Bechtold, N. Treese, T. Pop in Myocarditis Cardiomyopathy (1983)

  11. No Access

    Chapter

    Isosorbide Dinitrate: Pharmacokinetics After Intravenous Administration

    Isosorbide dinitrate (ISDN) is an important organic nitrate found therapeutically useful in its sublingual and oral forms in various cardiovascular diseases such as angina pectoris (1) and congestive heart fai...

    R. A. Morrison, D. Höhmann, T. Meinertz in Vasodilators in Chronic Heart Failure (1983)

  12. No Access

    Chapter

    Computertomographic Findings in Congestive Cardiomyopathy

    The contribution of non-invasive radiologic diagnostic procedures has thus far been rather insignificant in the diagnosis of cardiomyopathy. The mainstay has been the conventional chest X-ray. Estimation of di...

    M. Thelen, O. Hatz, K. J. Klose, T. Meinertz, W. Kaspar in Myocarditis Cardiomyopathy (1983)

  13. No Access

    Chapter

    Prevalence of Arrhythmias During 24-Hour Electrocardiographic Monitoring in Patients with Dilative Cardiomyopathy

    Clinical symptoms of dilative (congestive) cardiomyopathy (DCM) were generally attributed to left ventricular pump failure or thromboembolic complications. Only sporadic reports appeared documenting arrhythmia...

    T. Meinertz, W. Kasper, T. Hofmann, N. Treese, H. Bechtold in Myocarditis Cardiomyopathy (1983)

  14. No Access

    Chapter

    Repetitive Response to Ventricular Extrastimuli in Patients with Dilated Cardiomyopathy

    In dilated cardiomyopathy ventricular arrhythmias are frequently observed and may lead to sudden death from ventricular fibrillation [2, 3, 5]. Increased ventricular vulnerability therefore seems to exist in s...

    T. Pop, N. Treese, T. Meinertz, W. Kasper in Myocarditis Cardiomyopathy (1983)

  15. No Access

    Chapter

    Biochemical Findings in Serum of Patients with Congestive Cardiomyopathy: Is Serum Selenium Concentration a Possible Marker?

    The conventional methods of clinical chemistry, such as determination of enzyme activities in serum, are not suited for diagnosis or differential diagnosis of cardiomyopathy. Only in a few cases have we observ...

    W. Prellwitz, O. Oster, W. Kasper, T. Meinertz in Myocarditis Cardiomyopathy (1983)

  16. No Access

    Article

    Disposition of azapropazone in chronic renal and hepatic failure

    The disposition of azapropazone 600 mg i.v. was investigated in 6 healthy subjects, 13 patients with cirrhosis and 8 patients with renal failure. In healthy subjects the elimination half-life was 12.2±2.1 h (m...

    K. -H. Breuing, H. -J. Gilfrich, T. Meinertz in European Journal of Clinical Pharmacology (1981)

  17. No Access

    Article

    Haemodynamic effects of a single intravenous dose of lorcainide in patients with heart disease

    The cardiovascular effects of a single i.v. dose (2 mg/kg over 5 min) of lorcainide were studied in 14 patients with heart disease. In the haemodynamic part of the study (6 patients), the aortic and pulmonary ...

    T. Meinertz, F. Kersting, W. Kasper, H. Just in European Journal of Clinical Pharmacology (1980)

  18. No Access

    Chapter

    Anticoagulant Activity of the Enantiomers of Acenocoumarol in Man

    For the mono-coumarin derivatives warfarin and phen-procoumon it was shown that in man and rats the S(−) enantiomer is several times more potent as anticoagulant than the R(+) enantiomer. These stereoselective...

    T. Meinertz, W. Kasper, E. Jähnchen, J. Godbillon in Deutsche Pharmakologische Gesellschaft (1978)

  19. No Access

    Article

    Pharmacokinetic analysis of the interaction between dicoumarol and tolbutamide in man

    The effect of repeated administration of tolbutamide on the elimination and anticoagulant action of a single oral dose of dicoumarol 600 mg was studied in four healthy male subjects using a crossover design. I...

    E. Jähnchen, T. Meinertz, H. -J. Gilfrich in European Journal of Clinical Pharmacology (1976)

  20. No Access

    Article

    Effect of DB-c-AMP on mechanical characteristics of ventricular and atrial preparations of several mammalian species

    Conflicting results exist about the influence of cyclic N6-2′-O-dibutyryl-AMP (DB-c-AMP) on myocardial contractile force. The present study was designed to examine whether the positive inotropic action of DB-c-AM...

    T. Meinertz, H. Nawrath, H. Scholz in Naunyn-Schmiedeberg's Archives of Pharmaco… (1974)

previous disabled Page of 2